Table 4 The relapse-associated SNPs for patients with HSCT.

SNP	Genome position¹ (bp)	Gene/location	Source²	Disease/Status	Number of patients (%)			P^*
Donor genotype
rs111394117	32219436	NOTCH4, intron	rs394657	AML	A/A	A/G	G/G	0.0166
				Relapse	1 (6.7)	2 (13.3)	12 (80.0)
				Non-relapse	0 (0.0)	0 (0.0)	40 (100.0)
rs213210	33208047	RING1, promoter	rs107822	ALL	A/A	A/G	G/G	0.0285
				Relapse	3 (25.0)	8 (66.7)	1 (8.3)
				Non-relapse	10 (25.0)	12 (30.0)	18 (45.0)
Recipient genotype
rs79327197	33010635	HLA-DOA,	rs429916	ALL	A/A	A/G	G/G	0.0150
		promoter		Relapse	10 (66.7)	5 (33.3)	0 (0.0)
				Non-relapse	35 (94.6)	2 (5.4)	0 (0.0)
rs2009658	31538244	1.6 kb telomeric of	rs915654	ALL	C/C	C/G	G/G	0.0148
		LTA		Relapse	12 (80.0)	1 (6.7)	2 (13.3)
				Non-relapse	25 (67.6)	12 (32.4)	0 (0.0)
rs213210	33208047	RING1, promoter	rs107822	AML	A/A	A/G	G/G	0.0444
				Relapse	2 (8.3)	13 (54.2)	9 (37.5)
				Non-relapse	20 (34.5)	26 (44.8)	12 (20.7)
rs17220087	32813299	HLA-DOB, intron	rs2071479	AML	A/A	A/C	C/C	0.0465
				Relapse	0 (0.0)	0 (0.0)	25 (100.0)
				Non-relapse	0 (0.0)	8 (14.3)	48 (85.7)
				ALL	A/A	A/C	C/C	0.0311
				Relapse	0 (0.0)	3 (20.0)	12 (80.0)
				Non-relapse	0 (0.0)	1 (2.6)	37 (97.4)
rs17213693	32813344	HLA-DOB, intron	rs2071479	AML	C/C	C/G	G/G	0.0465
				Relapse	0 (0.0)	0 (0.0)	25 (100.0)
				Non-relapse	0 (0.0)	8 (14.3)	48 (85.7)
				ALL	C/C	C/G	G/G
				Relapse	0 (0.0)	3 (20.0)	12 (80.0)	0.0311
				Non-relapse	0 (0.0)	1 (2.6)	37 (97.4)
rs2070120	32813137	HLA-DOB, 3′UTR	rs2071479	ALL	A/A	A/G	G/G	0.0311
				Relapse	0 (0.0)	3 (20.0)	12 (80.0)
				Non-relapse	0 (0.0)	1 (2.6)	37 (97.4)

*Statistical analyses were performed by using genotypic test or Chi-square test.

Quick links

Search